相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel reporter system for neutralizing and enhancing antibody assay against dengue virus
Ke-Yu Song et al.
BMC MICROBIOLOGY (2014)
Callithrix penicillata: A feasible experimental model for dengue virus infection
Milene Silveira Ferreira et al.
IMMUNOLOGY LETTERS (2014)
Aedes aegypti Saliva Contains a Prominent 34-kDa Protein that Strongly Enhances Dengue Virus Replication in Human Keratinocytes
Pornapat Surasombatpattana et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Innate Antiviral Immune Signaling, Viral Evasion and Modulation by HIV-1
Arjun Rustagi et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Mosquito Saliva Serine Protease Enhances Dissemination of Dengue Virus into the Mammalian Host
Michael J. Conway et al.
JOURNAL OF VIROLOGY (2014)
Live Attenuated Tetravalent Dengue Virus Host Range Vaccine Is Immunogenic in African Green Monkeys following a Single Vaccination
Caitlin M. Briggs et al.
JOURNAL OF VIROLOGY (2014)
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
Maria Rosario Capeding et al.
LANCET (2014)
Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study
Jorge E. Osorio et al.
LANCET INFECTIOUS DISEASES (2014)
被撤回的出版物: Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity (Retracted article. See vol. 112, pg. E2738, 2015)
William B. Messer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Viral kinetics of primary dengue virus infection in non-human primates: A systematic review and individual pooled analysis
Benjamin M. Althouse et al.
VIROLOGY (2014)
Capsid protein: Evidences about the partial protective role of neutralizing antibody-independent immunity against dengue in monkeys
Lazaro Gil et al.
VIROLOGY (2014)
A rapid immunization strategy with a live-attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates
Yuping Ambuel et al.
FRONTIERS IN IMMUNOLOGY (2014)
Serotype-Specific Host Responses in Rhesus Macaques after Primary Dengue Challenge
Andrew C. Hickey et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
A Phase II, Randomized, Safety and Immunogenicity Study of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults
Stephen J. Thomas et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9-16 Years in Brazil
Gustavo H. Dayan et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates
Hsin-Wei Chen et al.
ARCHIVES OF VIROLOGY (2013)
Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection
Maria G. Guzman et al.
ARCHIVES OF VIROLOGY (2013)
Toll-Like Receptors in Human Papillomavirus Infection
Qiang Zhou et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2013)
Therapeutic antibodies as a treatment option for dengue fever
Kuan Rong Chan et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults
Janet E. McElhaney et al.
EXPERT REVIEW OF VACCINES (2013)
Fever versus fever: The role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus
Kathryn A. Hanley et al.
INFECTION GENETICS AND EVOLUTION (2013)
Innate immunity and HCV
Markus H. Heim
JOURNAL OF HEPATOLOGY (2013)
Experimental Dengue Virus Challenge of Human Subjects Previously Vaccinated With Live Attenuated Tetravalent Dengue Vaccines
Wellington Sun et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial
Anna P. Durbin et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
The genetic composition of populations of cynomolgus macaques (Macaca fascicularis) used in biomedical research
S. Kanthaswamy et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2013)
An Alphavirus Vector-Based Tetravalent Dengue Vaccine Induces a Rapid and Protective Immune Response in Macaques That Differs Qualitatively from Immunity Induced by Live Virus Infection
Laura J. White et al.
JOURNAL OF VIROLOGY (2013)
Dengue Virus Neutralization in Cells Expressing Fc Gamma Receptors
Tanu Chawla et al.
PLOS ONE (2013)
Vaccination of volunteers with low-dose, live-attenuated, dengue viruses leads to serotype-specific immunologic and virologic profiles
Janet C. Lindow et al.
VACCINE (2013)
Identifying protective dengue vaccines: Guide to mastering an empirical process
Scott B. Halstead
VACCINE (2013)
The Innate Immune Playbook for Restricting West Nile Virus Infection
Kendra M. Quicke et al.
VIRUSES-BASEL (2013)
Role of Innate Immunity against Human Papillomavirus (HPV) Infections and Effect of Adjuvants in Promoting Specific Immune Response
Alfredo Amador-Molina et al.
VIRUSES-BASEL (2013)
Aedes Mosquito Saliva Modulates Rift Valley Fever Virus Pathogenicity
Alain Le Coupanec et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Correction: Therapeutic Efficacy of Antibodies Lacking FcγR against Lethal Dengue Virus Infection Is Due to Neutralizing Potency and Blocking of Enhancing Antibodies
Katherine L. Williams et al.
PLoS Pathogens (2013)
Role of Humoral versus Cellular Responses Induced by a Protective Dengue Vaccine Candidate
Raphael M. Zellweger et al.
PLOS PATHOGENS (2013)
Rational Design of a Live Attenuated Dengue Vaccine: 2 '-O-Methyltransferase Mutants Are Highly Attenuated and Immunogenic in Mice and Macaques
Roland Zuest et al.
PLOS PATHOGENS (2013)
Can non-human primates serve as models for investigating dengue disease pathogenesis?
Kristina B. Clark et al.
FRONTIERS IN MICROBIOLOGY (2013)
Testing of Novel Dengue Virus 2 Vaccines in African Green Monkeys: Safety, Immunogenicity, and Efficacy
Katherine M. Smith et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Comparison of Plaque- and Enzyme-Linked Immunospot-Based Assays To Measure the Neutralizing Activities of Monoclonal Antibodies Specific to Domain III of Dengue Virus Envelope Protein
Lidong Liu et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development
Ravendra Garg et al.
EXPERT REVIEW OF VACCINES (2012)
Dengue virus-specific CD4+ and CD8+ T lymphocytes target NS1, NS3 and NS5 in infected Indian rhesus macaques
Katherine M. Mladinich et al.
IMMUNOGENETICS (2012)
Aedes aegypti Saliva Enhances Dengue Virus Infection of Human Keratinocytes by Suppressing Innate Immune Responses
Pornapat Surasombatpattana et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Recombinant Dengue Type 2 Viruses with Altered E Protein Domain III Epitopes Are Efficiently Neutralized by Human Immune Sera
Wahala M. P. B. Wahala et al.
JOURNAL OF VIROLOGY (2012)
Mosquito Bite Delivery of Dengue Virus Enhances Immunogenicity and Pathogenesis in Humanized Mice
Jonathan Cox et al.
JOURNAL OF VIROLOGY (2012)
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
Arunee Sabchareon et al.
LANCET (2012)
Association of human immune response to Aedes aegypti salivary proteins with dengue disease severity
C. Machain-Williams et al.
PARASITE IMMUNOLOGY (2012)
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
Ruklanthi de Alwis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Immunogenicity and safety of tetravalent dengue vaccine in 2-11 year-olds previously vaccinated against yellow fever: Randomized, controlled, phase II study in Piura, Peru
Claudio F. Lanata et al.
VACCINE (2012)
Immunogenicity and protective efficacy of a vaxfectin-adjuvanted tetravalent dengue DNA vaccine
Kevin R. Porter et al.
VACCINE (2012)
Broad neutralization of wild-type dengue virus isolates following immunization in monkeys with a tetravalent dengue vaccine based on chimeric Yellow Fever 17D/Dengue viruses
Veronique Barban et al.
VIROLOGY (2012)
Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo
Katherine L. Williams et al.
VIROLOGY (2012)
Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 y Phase II randomized controlled trial in Singapore
Yee Sin Leo et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Dengue Virus Infection-Enhancing Activity in Serum Samples with Neutralizing Activity as Determined by Using FcγR-Expressing Cells
Meng Ling Moi et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Primary Vaccination with Low Dose Live Dengue 1 Virus Generates a Proinflammatory, Multifunctional T Cell Response in Humans
Janet C. Lindow et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Immunization of Mice with Recombinant Mosquito Salivary Protein D7 Enhances Mortality from Subsequent West Nile Virus Infection via Mosquito Bite
Krystle L. Reagan et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Efficacy of a Tetravalent Chimeric Dengue Vaccine (DENVax) in Cynomolgus Macaques
Jorge E. Osorio et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Heterotypic Dengue Infection with Live Attenuated Monotypic Dengue Virus Vaccines: Implications for Vaccination of Populations in Areas Where Dengue Is Endemic
Anna P. Durbin et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Decreased Dengue Replication and an Increased Anti-viral Humoral Response with the use of Combined Toll-Like Receptor 3 and 7/8 Agonists in Macaques
Carlos A. Sariol et al.
PLOS ONE (2011)
Live-attenuated Tetravalent Dengue Vaccine in Dengue-naive Children, Adolescents, and Adults in Mexico City Randomized Controlled Phase 1 Trial of Safety and Immunogenicity
Jorge Poo et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
Jorge E. Osorio et al.
VACCINE (2011)
Immunogenicity and protective efficacy of a psoralen-inactivated dengue-1 virus vaccine candidate in Aotus nancymaae monkeys
Ryan C. Maves et al.
VACCINE (2011)
Next generation dengue vaccines: A review of candidates in preclinical development
Julia Schmitz et al.
VACCINE (2011)
Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial
Charmagne G. Beckett et al.
VACCINE (2011)
Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine
Anna P. Durbin et al.
VACCINE (2011)
The Human Antibody Response to Dengue Virus Infection
Wahala M. P. B. Wahala et al.
VIRUSES-BASEL (2011)
A Single Dose of the DENV-1 Candidate Vaccine rDEN1Δ30 Is Strongly Immunogenic and Induces Resistance to a Second Dose in a Randomized Trial
Anna P. Durbin et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Genetic Characterization of Specific Pathogen-Free Rhesus Macaque (Macaca mulatta) Populations at the California National Primate Research Center (CNPRC)
Sree Kanthaswamy et al.
AMERICAN JOURNAL OF PRIMATOLOGY (2010)
Dengue virus-induced hemorrhage in a nonhuman primate model
Nattawat Onlamoon et al.
BLOOD (2010)
Discrepancy in Dengue Virus Neutralizing Antibody Titers between Plaque Reduction Neutralizing Tests with Fcγ Receptor (FcγR)-Negative and FcγR-Expressing BHK-21 Cells
Meng Ling Moi et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes in Flavivirus-Naive Adults
Dennis Morrison et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Detecting signatures of inter-regional and inter-specific hybridization among the Chinese rhesus macaque specific pathogen-free (SPF) population using single nucleotide polymorphic (SNP) markers
Sree Kanthaswamy et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2010)
Aedes aegypti Saliva Alters Leukocyte Recruitment and Cytokine Signaling by Antigen-Presenting Cells during West Nile Virus Infection
Bradley S. Schneider et al.
PLOS ONE (2010)
Report of an NIAID workshop on dengue animal models
M. Cristina Cassetti et al.
VACCINE (2010)
Development of a recombinant tetravalent dengue virus vaccine: Innmunogenicity and efficacy studies in mice and monkeys
David E. Clements et al.
VACCINE (2010)
Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy
Monika Simmons et al.
VIROLOGY (2010)
Dengue Plaque Reduction Neutralization Test (PRNT) in Primary and Secondary Dengue Virus Infections: How Alterations in Assay Conditions Impact Performance
Stephen J. Thomas et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2009)
Antibodies Induced by Dengue Virus Type 1 and 2 Envelope Domain III Recombinant Proteins in Monkeys Neutralize Strains with Different Genotypes
Lidice Bernardo et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Advances in dengue vaccine development
Kanakatte Raviprakash et al.
HUMAN VACCINES (2009)
Passage of Dengue Virus Type 4 Vaccine Candidates in Fetal Rhesus Lung Cells Selects Heparin-Sensitive Variants That Result in Loss of Infectivity and Immunogenicity in Rhesus Macaques
German Anez et al.
JOURNAL OF VIROLOGY (2009)
Scientific consultation on cell mediated immunity (CMI) in dengue and dengue vaccine development
Stephen J. Thomas et al.
VACCINE (2009)
Dengue virus neutralization is modulated by IgG antibody subclass and Fcγ receptor subtype
W. W. Shanaka I. Rodrigo et al.
VIROLOGY (2009)
Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
W. M. P. B. Wahala et al.
VIROLOGY (2009)
Limited replication of yellow fever 17DD and 17D-Dengue recombinant viruses in rhesus monkeys
Gisela F. Trindade et al.
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2008)
Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates
Lidice Bernard et al.
ANTIVIRAL RESEARCH (2008)
Anamnestic antibody response after viral challenge in monkeys immunized with dengue 2 recombinant fusion proteins
Lidice Bernardo et al.
ARCHIVES OF VIROLOGY (2008)
Hybridization and Stratification of Nuclear Genetic Variation in Macaca mulatta and M-fascicularis
Sree Kanthaswamy et al.
INTERNATIONAL JOURNAL OF PRIMATOLOGY (2008)
A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus
Kanakatte Raviprakash et al.
JOURNAL OF VIROLOGY (2008)
The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response
Bradley S. Schneider et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2008)
Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects
Bruno Guy et al.
VACCINE (2008)
Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4
Joseph E. Blaney et al.
VACCINE (2008)
Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses
John T. Roehrig et al.
VIRAL IMMUNOLOGY (2008)
Serotype-specificity of recombinant fusion proteins containing domain III of dengue virus
Alienys Izquierdo et al.
VIRUS RESEARCH (2008)
Primary and secondary infections of Macaca fascicularis monkeys with Asian and American genotypes of dengue virus 2
Lidice Bernardo et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4) -neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody
Ching-Juh Lai et al.
JOURNAL OF VIROLOGY (2007)
Prior Exposure to Uninfected Mosquitoes Enhances Mortality in Naturally-Transmitted West Nile Virus Infection
Bradley S. Schneider et al.
PLOS ONE (2007)
Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization
Annette A. Kraus et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
A heterologous DNA prime-Venezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaquesv
Lan Chen et al.
JOURNAL OF VIROLOGY (2007)
Efficacy of a live attenuated tetravalent candidate dengue vaccine in naive and previously infected cynomolgus macaques
Penelopie Koraka et al.
VACCINE (2007)
Prospects for a dengue virus vaccine
Stephen S. Whitehead et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Characterization of humoral and cellular immune responses in cynomolgus macaques upon primary and subsequent heterologous infections with dengue viruses
Penelopie Koraka et al.
MICROBES AND INFECTION (2007)
Wild dengue virus types 1, 2 and 3 viremia in rhesus monkeys
M. S. Freire et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2007)
Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention
Ana P. Goncalvez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Δ30 with those of DEN1
Joseph E. Blaney et al.
VIROLOGY JOURNAL (2007)
Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein Vaccines in rhesus macaques
Monika Simmons et al.
JOURNAL OF VIROLOGY (2006)
A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypeg in rhesus macaques
Kanakatte Raviprakash et al.
VIROLOGY (2006)
The live attenuated dengue serotype 1 vaccine rDEN1Δ30 is safe and highly immunogenic in healthy adult volunteers
Anna P. Durbin et al.
HUMAN VACCINES (2006)
Protection of rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination
Wellington Sun et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
An immunocytometric assay based on dengue infection via DC-SIGN permits rapid measurement of anti-dengue neutralizing antibodies
Nicole C. Martin et al.
JOURNAL OF VIROLOGICAL METHODS (2006)
A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates
L Hermida et al.
VACCINE (2006)
Potentiation of West Nile encephalitis by mosquito feeding
BS Schneider et al.
VIRAL IMMUNOLOGY (2006)
Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax™-DEN2) vaccine:: Phase I clinical trial for safety and immunogenicity
Farshad Guirakhoo et al.
HUMAN VACCINES (2006)
Evaluation of immunity and protective efficacy of a dengue-3 premembrane and envelope DNA vaccine in Aotus nancymae monkeys
PJ Blair et al.
VACCINE (2006)
Attenuation and immunogenicity of recombinant yellow fever 17D-dengue type 2 virus for rhesus monkeys
R Galler et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2005)
An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model
JR Putnak et al.
VACCINE (2005)
Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys
JE Blaney et al.
JOURNAL OF VIROLOGY (2005)
Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys
TJ Kochel et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates
F Guirakhoo et al.
JOURNAL OF VIROLOGY (2004)
Introduction of mutations into the non-structural genes or 3′ untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity
KA Hanley et al.
VACCINE (2004)
Aedes aegypti salivary gland extracts modulate anti-viral and TH1/TH2 cytokine responses to Sindbis virus infection
BS Schneider et al.
VIRAL IMMUNOLOGY (2004)
Modulation of Dengue virus infection of dendritic cells by Aedes aegypti saliva
DB Ader et al.
VIRAL IMMUNOLOGY (2004)
Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys
K Raviprakash et al.
VIROLOGY (2003)
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
J Mongkolsapaya et al.
NATURE MEDICINE (2003)
A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3 ' untranslated region is highly attenuated and immunogenic in monkeys
SS Whitehead et al.
JOURNAL OF VIROLOGY (2003)
Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: Genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates
F Guirakhoo et al.
VIROLOGY (2002)
Derivation and characterization of a dengue type 1 host range-restricted mutant virus that is attenuated and highly immunogenic in monkeys
L Markoff et al.
JOURNAL OF VIROLOGY (2002)
Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine
F Guirakhoo et al.
JOURNAL OF VIROLOGY (2001)
Bispecific monoclonal antibodies mediate binding of dengue virus to erythrocytes in a monkey model of passive viremia
CS Hahn et al.
JOURNAL OF IMMUNOLOGY (2001)
A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys
TJ Kochel et al.
VACCINE (2000)
Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge
R Men et al.
VACCINE (2000)
Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques
K Raviprakash et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates
F Guirakhoo et al.
JOURNAL OF VIROLOGY (2000)
分享论文
